Low-level Laser and Lifestyle Modifications (LLLT)
Primary Purpose
Overweight and Obesity, Weight Loss
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Low Level Laser Therapy
Sham (placebo)
Sponsored by

About this trial
This is an interventional treatment trial for Overweight and Obesity focused on measuring BMI, Fat Mass, Weight Loss, Body Circumference Reduction
Eligibility Criteria
Inclusion Criteria:
- 18 years of age or older
- have a BMI 25-39.9 kg/m2
- be able to participate fully in all aspects of the study; and
- have understood and signed study informed consent
Exclusion Criteria:
- have used weight loss medications or participated in a weight loss program within the past 30 days
- are currently taking medications or supplements known to affect weight, such as insulin or sulfonylurea, prednisone or garcinia cambrogia
- have had weight fluctuations of 5 pounds or more in the past month
- have an implanted device (including pacemaker or lap band) in the targeted area of LLLT
- have a known active eating disorder
- have a known, active, untreated clinically significant psychiatric condition (alcohol or substance abuse, psychosis, bipolar disorder, or depression)
- have used an investigational drug within 30 days of study enrollment
Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the low-level laser therapy treatment phase and are unwilling to use a reliable form of contraception. Acceptable forms include:
- Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants
- Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm)
- Intrauterine device (IUD)
- Total hysterectomy or tubal ligation
- Abstinence (no sex)
- have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease
- have current uncontrolled hypertension (systolic > 160 mm Hg or diastolic > 95 mm Hg) documented on 2 separate occasions
- have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as uncontrolled diabetes type 2) or active cancer or are within 1 year of cancer remission
- surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc. within 12 months prior to enrollment
- medical, physical, or other contraindications for body sculpting/weight loss
- any medical condition known to affect weight levels and/or to cause bloating or swelling
- a diagnosis of, and/or taking medication for, irritable bowel syndrome
- active infection, wound or other external trauma to the areas to be treated with the laser
- known photosensitivity disorder
- current active cancer or currently receiving treatment for cancer; or
- have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence
Sites / Locations
- Mayo ClinicRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Group 1 - LLLT
Group 2 - SHAM
Arm Description
Subject receive Laser treatments and Lifestyle Modifications
Subject receives Sham Laser treatments and Lifestyle Modifications
Outcomes
Primary Outcome Measures
Amount of fat mass loss
Compare the amount of fat mass loss at the end of treatments
Secondary Outcome Measures
Full Information
NCT ID
NCT05083442
First Posted
October 6, 2021
Last Updated
June 6, 2023
Sponsor
Mayo Clinic
Collaborators
Erchonia Corporation
1. Study Identification
Unique Protocol Identification Number
NCT05083442
Brief Title
Low-level Laser and Lifestyle Modifications
Acronym
LLLT
Official Title
A Feasibility Study Addressing the Adjunct Use of Low-Level Laser to Mayo Lifestyle Modification Education and Wellness Coaching for Reducing Central Adiposity and Fat Mass
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
Collaborators
Erchonia Corporation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this research study is to evaulate the effectiveness of Low Level Laser Therapy in combination with Lifestyle Modifications in helping people reduce the extra weight and size in the central body region
Detailed Description
Subjects will undergo Low Level Laser Therapy or Sham (placebo) treatments while incorporating lifestyle modifications through of wellness coaching.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight and Obesity, Weight Loss
Keywords
BMI, Fat Mass, Weight Loss, Body Circumference Reduction
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized clinical trial where subjects are placed into 2 different study arms. Subjects randomized to 2 groups that either receive Low Level Laser therapy with lifestyle modifications or Sham (placebo) with Lifestyle Modifications.
Masking
Participant
Masking Description
Randomization will be set up by a statistician through REDCap, the data collection system utilized for the study.
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group 1 - LLLT
Arm Type
Active Comparator
Arm Description
Subject receive Laser treatments and Lifestyle Modifications
Arm Title
Group 2 - SHAM
Arm Type
Sham Comparator
Arm Description
Subject receives Sham Laser treatments and Lifestyle Modifications
Intervention Type
Device
Intervention Name(s)
Low Level Laser Therapy
Intervention Description
Non-surgical cosmetic treatment which can be used by individuals intending to reduce size of the mid-section
Intervention Type
Other
Intervention Name(s)
Sham (placebo)
Intervention Description
Use of sham (placebo) option
Primary Outcome Measure Information:
Title
Amount of fat mass loss
Description
Compare the amount of fat mass loss at the end of treatments
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18 years of age or older
have a BMI 25-39.9 kg/m2
be able to participate fully in all aspects of the study; and
have understood and signed study informed consent
Exclusion Criteria:
have used weight loss medications or participated in a weight loss program within the past 30 days
are currently taking medications or supplements known to affect weight, such as insulin or sulfonylurea, prednisone or garcinia cambrogia
have had weight fluctuations of 5 pounds or more in the past month
have an implanted device (including pacemaker or lap band) in the targeted area of LLLT
have a known active eating disorder
have a known, active, untreated clinically significant psychiatric condition (alcohol or substance abuse, psychosis, bipolar disorder, or depression)
have used an investigational drug within 30 days of study enrollment
Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the low-level laser therapy treatment phase and are unwilling to use a reliable form of contraception. Acceptable forms include:
Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants
Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm)
Intrauterine device (IUD)
Total hysterectomy or tubal ligation
Abstinence (no sex)
have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease
have current uncontrolled hypertension (systolic > 160 mm Hg or diastolic > 95 mm Hg) documented on 2 separate occasions
have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as uncontrolled diabetes type 2) or active cancer or are within 1 year of cancer remission
surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc. within 12 months prior to enrollment
medical, physical, or other contraindications for body sculpting/weight loss
any medical condition known to affect weight levels and/or to cause bloating or swelling
a diagnosis of, and/or taking medication for, irritable bowel syndrome
active infection, wound or other external trauma to the areas to be treated with the laser
known photosensitivity disorder
current active cancer or currently receiving treatment for cancer; or
have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shawn C Fokken, BS
Phone
507-293-2740
Email
GIMResearchStudies@mayo.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Stephanie Lindeen, RN
Phone
507-293-2740
Email
GIMResearchStudies@mayo.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ivana T Croghan, PhD
Organizational Affiliation
Professor of Medicine, College of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ryan T Hurt, MD, PhD
Organizational Affiliation
Mayo Clinic
Official's Role
Study Director
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stephanie Lindeen, RN
Phone
507-293-2740
Email
gimresearchstudies@mayo.edu
First Name & Middle Initial & Last Name & Degree
Shawn Fokken, CCRP
Phone
507-293-2740
Email
gimresearchstudies@mayo.edu
First Name & Middle Initial & Last Name & Degree
Ivana Croghan, PhD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Low-level Laser and Lifestyle Modifications
We'll reach out to this number within 24 hrs